Approximately 40% of the European population is allergic to pollen, and their symptoms cause the estimated loss of 100 million school and work days every year. Traditional treatment is ...

Mouse and human data hint that biological differences may shape drug bioavailability in ways clinical trials often overlook ...

A study in mice reports a CRISPR/Cas9 gene-editing delivery system, capable of bypassing the blood-brain-barrier and modulating neuronal receptor pathways, to treat chronic anxiety. Troy Rohn and ...

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of a ...